Adenosine A2a Receptor Antikörper (N-Term)
Kurzübersicht für Adenosine A2a Receptor Antikörper (N-Term) (ABIN929401)
Target
Alle Adenosine A2a Receptor (ADORA2A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- ADORA2 A antibody was raised in rabbit using the N terminal of ADORA2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ADORA2A Blocking Peptide, (ABIN5611958), is also available for use as a blocking control in assays to test for specificity of this ADORA2A antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Adenosine A2a Receptor (ADORA2A)
-
Andere Bezeichnung
- ADORA2A
-
Hintergrund
- ADORA2A is one of several receptor subtypes for adenosine. The activity of the protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. ADORA2A is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine. Synonyms: Polyclonal ADORA2A antibody, Anti-ADORA2A antibody, adenosine A2a receptor antibody, ADORA2 antibody, RDC8 antibody, hA2aR antibody.
-
Pathways
- Neurotrophin Signalübertragung, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Target
-